Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery

Background The efficacy of neoadjuvant therapy (NAT), including neoadjuvant chemotherapy (NAC) and neoadjuvant chemo-radiotherapy (NACRT), for patients with borderline resectable pancreatic cancer (BRPC) has not been elucidated. This study aimed to clarify the efficacy of NAC and NACRT for patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2019-06, Vol.26 (6), p.1629-1636
Hauptverfasser:	Nagakawa, Yuichi, Sahara, Yatsuka, Hosokawa, Yuichi, Murakami, Yoshiaki, Yamaue, Hiroki, Satoi, Sohei, Unno, Michiaki, Isaji, Shuji, Endo, Itaru, Sho, Masayuki, Fujii, Tsutomu, Takishita, Chie, Hijikata, Yosuke, Suzuki, Shuji, Kawachi, Shigeyuki, Katsumata, Kenji, Ohta, Tetsuo, Nagakawa, Takukazu, Tsuchida, Akihiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Biopsy Chemoradiotherapy CHEMOTHERAPY COMBINED THERAPY LYMPH NODES Lymphatic system Medical prognosis Medicine Medicine & Public Health METASTASES NEOPLASMS Oncology PANCREAS Pancreatic cancer Pancreatic Tumors PATIENTS Radiation therapy RADIOLOGY AND NUCLEAR MEDICINE RADIOTHERAPY SURGERY Surgical Oncology Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!